Ionis Pharmaceuticals (IONS) Asset Utilization Ratio (2010 - 2026)

Ionis Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.21 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio fell 35.39% year-over-year to 0.21; the TTM figure through Jun 2026 stood at 0.21 (down 35.39% YoY), while the FY2025 annual figure was 0.29, up 22.89% from the prior year.
• Asset Utilization Ratio for Q2 2026 stood at 0.21, down from 0.25 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.36 in Q3 2022, with the low at 0.21 in Q3 2023.
• The 5-year median for Asset Utilization Ratio is 0.27 (2023), against an average of 0.27.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio soared 133.23% in 2022, then slumped 41.97% in 2023.
• Ionis Pharmaceuticals' Asset Utilization Ratio stood at 0.24 in 2022, then increased by 12.18% to 0.27 in 2023, then declined by 12.84% to 0.23 in 2024, then advanced by 24.2% to 0.29 in 2025, then decreased by 26.9% to 0.21 in 2026.
• Business Quant data shows IONS's Asset Utilization Ratio at 0.21 in Q2 2026, 0.25 in Q1 2026, and 0.29 in Q4 2025.